1/30
Looks like no tags are added yet.
cancer and global incidence statistics
somatic cell level genetic disease
genes inherited or created
~50% asia
~25% europe and americas
<10% africa and oceania
genetic alterations in cancer
single nucleotide substitutions
large-scale chromosomal rearrangements
benign vs malignant tumors
can’t metastasis (spread in body) vs can
cancer cells clonal origin
cancer cells in primary and secondary tumors originate from a common ancestor
2 fundamental properties of cancer
abnormal proliferation
metastasis
driver mutations
mutation in a cancer cell that contributes to tumor progression
passenger mutation
mutations that accumulate in cancer cells that have no direct contribution to the development of cancer
where do driver genes occur, and what do they control?
in oncogenes and tumor suppressor genes
DNA damage response
chromatin modification
cell cycle regulation
apoptosis
why is cancer very rarely a single mutation in a single gene?
thorough checks in interphase of cell cycle
list 4 hallmarks of cancer
resisting cell death
activating invasion and metastasis
inducing angiogenesis (recruiting white blood cells for nutrients)
sustaining proliferating signaling ( turn on response to growth factor)
cancer incidence rises exponentially with ___.
delay between _______ exposure and appearance of cancer
each step in ___________ is the result of 2 or more genetic alterations
age
carcinogen
tumorigenesis
cancer that propagates through ___________ has an advantage in growth and survival
clonal expansion
cancer cells contain genetic defects, affecting …
genomic stability
DNA repair
chromatin modifications
cell-cycle regulation
genomic instability and defective DNA repair example
philadelphia chromosome
translocation of chromosomes 9 and 22
causes immature white blood cells to divide rapidly and blocks apoptosis
interphase and cell cycle phases
interval between mitotic divisions
G1 prepares DNA synthesis
S DNA replication
(proliferation)
G2 growth and preparation to divide
mitosis
G0 metabolically active, no growth or dividing- quiescence
cell cycle control and checkpoints
cyclin B levels increase in G2 and binds to inactive CDK1
active CDK1/cyclin B phosphorylate M phase proteins
Cyclin B degraded in late M phase
control of apoptosis
caspases package apoptotic bodies
caspases
proteins which breakdown cellular components
proto-oncogene
transcription factors that stimulate expression of other genes/molecules that stimulate cell division
oncogene
mutated proto-oncogenes or ones with altered expression
tumor-suppressor genes
normally regulated cell cycle checkpoint or inactivation of apoptosis
ras proto-oncogene
signal transduction function
GTP-binding protein with GTPase activity
acts as a molecular switch, activation or repression of gene transcription
TP53 tumor-suppressor gene
continuously synthesized but rapidly degraded
MDM2 interacts with p53 for ubiquitilation, tumor suppressor protein
p53 respons to DNA damage with cell-cycle arrest, DNA repair, apoptosis
what situations increase p53 activation
stress
Double strand breaks
Chemical damage
DNA-repair intermediates
Metastasis
invasion
intravasation
circulation
extravasation
colonization
metastasis- invasion
cancer moves into surrounding tissue
metastasis- circulation
cancer enters the vessels circulation throughout body as a single cell or cluster
metastasis- intravasation
cancer enters blood cells
metastasis- extravasation
cancer exits blood vessel
metastasis-colonization
cancer pulls in other cells for survival, creates new microenvironment
chemotherapy vs gene targeted therapy
targets all rapidly dividing cells
focuses on specific molecular changes that focuses on tumor growth